Cytokinetics Inc (CYTK) returns
Cytokinetics returns over 10 years
$1,000 invested in Cytokinetics ten years ago was worth $6,467 at the close on October 30, 2026, with dividends reinvested: an average return of 20.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -4.4% | — | $955.70 | -0.9% |
| 3 months | -21.7% | — | $783.26 | +2.1% |
| Year to date | -0.9% | — | $991.34 | +11.7% |
| 1 year | +1.2% | — | $1,012 | +12.4% |
| 3 years | +96.3% | +25.2% | $1,963 | +88.5% |
| 5 years | +80.4% | +12.5% | $1,804 | +76.0% |
| 10 years | +546.7% | +20.5% | $6,467 | +316.6% |
Cytokinetics return by calendar year
| Year | CYTK | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -0.9% | +11.7% | -12.6% |
| 2025 | +35.1% | +17.7% | +17.4% |
| 2024 | -43.7% | +24.9% | -68.5% |
| 2023 | +82.2% | +26.2% | +56.0% |
| 2022 | +0.5% | -18.2% | +18.7% |
| 2021 | +119.3% | +28.7% | +90.6% |
| 2020 | +95.9% | +18.4% | +77.5% |
| 2019 | +67.9% | +31.2% | +36.7% |
| 2018 | -22.5% | -4.6% | -17.9% |
| 2017 | -32.9% | +21.7% | -54.6% |
| 2016 | +16.2% | +12.0% | +4.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CYTK financials
No forecast, no recommendation. This page describes Cytokinetics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.